Enzalutamide Impurity-A, PurCert
PurCert
Properties
| Assay Purity | >=99% |
| Density | 1.41 ± 0.1 g/cm3 |
| Form | Solid |
Safety Information
| Hazard Statement(s) | H302-H315-H319 |
| Precautionary Statement | P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330 |
| GHS Pictogram |
|
| Signal word | Warning |
| Storage Temp. | 2-8°C |
Description
Application
Enzalutamide Impurity-A is used in analytical method development method validation quality control testing stability studies and regulatory compliance activities in pharmaceutical manufacturing.
Purpose
The purpose of Enzalutamide Impurity-A is to serve as a reference standard for identifying monitoring and controlling impurities during the development and quality testing of Enzalutamide drug substances and formulations
General Description
Enzalutamide Impurity-A is a process-related impurityintermediate associated with the manufacture of the anti-cancer drug Enzalutamide chemically identified as O-Methyl (4-cyano-3-(trifluoromethyl)phenyl)carbamothioate
Documents
| SDS | |
| COA | |
| Specification | |
| Bulk quote order form | |
| Sample COA |